NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Due to the lapse in federal government funding, NASA is not updating this website. We sincerely regret this inconvenience.

Back to Results
Crew State and Risk Model (CSRM) - Medication Impacts on Physiologic Models for Exploration Class EVA Predictive Modeling and OperationsEVA and Environmental Physiology Laboratory (EEPL) wanted to expand upon the previous CSRM Physiologic Map to visually demonstrate the impact of medications on various modeling inputs that map to the seven physiologic models. It is acknowledged various physiologic states present during EVA could impact drug pharmacokinetics (i.e. pressure changes, core body temperature), which could impact pharmacodynamics. However, that is outside the scope of this document. The medications below represent the authors’ assumption of what medications will be available and able to impact an Artemis EVA and do not include the full ISS formulary, a final Artemis medical kit, or additional personal medications for individual crewmember’s chronic medical conditions.
Document ID
20240013840
Acquisition Source
Johnson Space Center
Document Type
Poster
Authors
Emma Ives
(Johnson Space Center Houston, United States)
Dan Buckland
(Johnson Space Center Houston, United States)
Bradley Hoffmann
(Johnson Space Center Houston, United States)
Shayne York
(JES Tech (United States) Houston, Texas, United States)
Date Acquired
October 31, 2024
Publication Date
November 1, 2024
Publication Information
Publisher: National Aeronautics and Space Administration
Subject Category
Aerospace Medicine
Meeting Information
Meeting: Aerospace Medical Clerkship
Location: Houston, TX
Country: US
Start Date: October 1, 2024
End Date: November 1, 2024
Sponsors: National Aeronautics and Space Administration
Funding Number(s)
CONTRACT_GRANT: NNJ15HK11B
Distribution Limits
Public
Copyright
Public Use Permitted.
Technical Review
Single Expert
No Preview Available